Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 May 3;26(1):1073274819846593. doi: 10.1177/1073274819846593

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2019

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 5. — Mannose-binding lectin 2 (MBL2) reversed the tumor-promoting effects of miR-942-3p in hepatocellular carcinoma (HCC) cells. A, Quantitative polymerase chain reaction (qPCR) and Western blot analysis of the transfection efficiency of MBL2 plasmid or si-MBL2 in LO2 or HepG2 cell line. B and C, 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) analysis of the cell viability after cotransfection with miR-942-3p mimic and MBL2 plasmid or miR-942-3pinhibitor and si-MBL2 in HCC cells. D and E, Transwell analysis of the cell invasive potential after cotransfection of miR-942-3p mimic and MBL2 plasmid or miR-942-3p inhibitor and si-MBL2 in HCC cells. Data were given as mean ± standard error of the mean of 3 experiments. *P< .05; **P< .01.